FDA approves new treatment for VAP
On June 3, the FDA approved a new indication for Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial…
Uncategorized
FDA approves treatment for episodic cluster headache
On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. (more…)
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone…
FDA authorizes marketing of Zika diagnostic test
On May 23, the FDA authorized marketing of ZIKV Detect 2.0 IgM Capture ELISA, the first diagnostic test for detecting Zika virus immunoglobulin antibodies in…
FDA approves first anticoagulant for VTE in pediatric patients
On May 16, the FDA approved Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients 1 month…
AHRQ releases new report on infertility management
AHRQ’s new report on management of infertility evaluates the effectiveness and safety of treatments for common causes. (more…)
Tactic for overcoming vaccine hesitancy identified
A study in Vaccines reports that exposing people to the pain and suffering caused by vaccine-preventable diseases is more effective than simply providing vaccine…
National Academy of Medicine’s Action Collaborative on Clinician Well-being and Resilience
A solution-focused strategy is designed to curtail the burnout epidemic. Takeaways: Burnout affects more than half of nurses, physicians, and other healthcare providers. To…
FDA approves new nasal spray for treatment-resistant depression
On March 5, the FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for treatment-resistant depression, but it’s only available through…
Nurses assess concerns at immigration detention center
Just about everyone has heard about the recent deaths of immigrants and asylum seekers being held in U.S. facilities. But did you know that…
Making Workforce Data Management a Priority
We will present a 1-hour webinar highlighting the importance of patient-centered, data-driven workforce management in healthcare settings. Topics covered will include: Why you need…
Why don’t people get vaccinated?
A new study in the Proceedings of the Royal Society B says that an answer to the question is “hysteresis loop” and uses the…
FDA approves new treatment for VAP
On June 3, the FDA approved a new indication for Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and…
FDA approves treatment for episodic cluster headache
On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. (more…)
FDA approves first PI3K inhibitor for breast cancer
On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men,…
FDA authorizes marketing of Zika diagnostic test
On May 23, the FDA authorized marketing of ZIKV Detect 2.0 IgM Capture ELISA, the first diagnostic test for detecting Zika virus immunoglobulin…
FDA approves first anticoagulant for VTE in pediatric patients
On May 16, the FDA approved Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients…
AHRQ releases new report on infertility management
AHRQ’s new report on management of infertility evaluates the effectiveness and safety of treatments for common causes. (more…)
Tactic for overcoming vaccine hesitancy identified
A study in Vaccines reports that exposing people to the pain and suffering caused by vaccine-preventable diseases is more effective than simply…
National Academy of Medicine’s Action Collaborative on Clinician Well-being and Resilience
A solution-focused strategy is designed to curtail the burnout epidemic. Takeaways: Burnout affects more than half of nurses, physicians, and other healthcare…
FDA approves new nasal spray for treatment-resistant depression
On March 5, the FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for treatment-resistant depression, but it’s only…
Nurses assess concerns at immigration detention center
Just about everyone has heard about the recent deaths of immigrants and asylum seekers being held in U.S. facilities. But did you…
Making Workforce Data Management a Priority
We will present a 1-hour webinar highlighting the importance of patient-centered, data-driven workforce management in healthcare settings. Topics covered will include: Why…
Why don’t people get vaccinated?
A new study in the Proceedings of the Royal Society B says that an answer to the question is “hysteresis loop” and…
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.